Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has issued an update.
Consun Pharmaceutical Group Ltd. has announced the appointment of Mr. Young Yuk Chuen David as an executive director and Mr. Duan Weiwu as an independent non-executive director, effective from April 8, 2025. Mr. Young will focus on international investment projects and overseas business development, while Mr. Duan will contribute his extensive legal expertise to the audit and nomination committees. These appointments are expected to enhance the company’s strategic direction and governance, potentially impacting its market positioning and stakeholder relations positively.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company involved in the pharmaceutical industry, focusing on pharmaceutical commerce, research and development, and providing commercial legal services related to pharmaceuticals.
YTD Price Performance: -11.65%
Average Trading Volume: 1,867
Technical Sentiment Signal: Strong Sell
Current Market Cap: €897.7M
See more data about 1681 stock on TipRanks’ Stock Analysis page.